The Venture Codex Logo

The Venture Codex

Palisades Growth Capital

11726 San Vicente Blvd Ste 450, Los Angeles, California, 90049, United States

Overview

We are a California-based private equity investor focused on providing growth stage capital to mid-sized enterprise software and tech-enabled companies. We focus on businesses with strong products in growing markets where we can facilitate a change in performance by scaling sales, strengthening leadership, and enhancing operations.

Total investments
8
Lead investments
4
Investments · 12mo
0
Active investors
3

Sector focus

  • Enterprise
  • Mobile
  • Software
Visit website

Investment portfolio

  • Gento

    Led · Series A · Feb 2020

    Gento (formerly Nursing Without Walls) operates a platform and mobile app that provides on-demand staffing and care-delivery management to home health agencies and skilled nursing facilities. Led by CEO Victor Gajendran, the company’s technology platform has been used for over 75,000 visits. In October 2020 Gento raised a $5M Series A to support its growth. The company said it will use the funds to expand nationwide and to improve care delivery through its technology. The article notes Gento has raised over $7M to date. Operations and product focus remain centered on matching staffing demand and managing visits via its platform and app.

  • AiCure

    Led · Series C · Nov 2019

    AiCure develops AI-driven software and analytics to enhance patient engagement, digital biomarkers, and sponsor insights in clinical trials. The company’s platform is positioned to improve monitoring and outcomes for life‑science sponsors running trials. In 2023 AiCure was granted seven new U.S. patents, bringing its total U.S. patent count to 86, with additional patents issued globally. On January 25, 2024, AiCure completed a $12M loan refinancing and raised an additional $4M+ from existing investors. The company said the proceeds will be used to invest in research and development, expand operations, and enhance its products and services. AiCure also added two senior hires: Sondra Pepe as SVP of Product Management and Josh Wilson as SVP of Operations. AiCure is an AI-driven healthcare platform that uses artificial intelligence to see, hear and understand how people respond to treatment in clinical trials and patient care. Its technologies are clinically proven to measure and modify patient behavior, helping keep patients engaged and optimized for treatment and to evaluate treatment effectiveness. The company holds more than 100 registered patents and works with global clients in more than 25 countries. AiCure was founded in 2010 and is led by CEO Adam Hanina. The company is based in New York City. It raised $24.5M in a Series C and intends to use the funds to accelerate its business activities. AiCure offers a mobile software-as-a-service platform that uses machine learning, computer vision, and big data to visually confirm patients’ medication ingestion. The technology has been validated against drug levels in blood samples and across patient populations including elderly stroke patients and participants in schizophrenia and HIV prevention trials. AiCure partners with pharmaceutical companies and government institutions to monitor medication adherence and optimize treatment models. The company is led by CEO Adam Hanina and operates from New York City. Financially, AiCure completed a Series A financing to support its operations and partnerships. The platform targets clinical-trial and treatment-adherence use cases through its AI-driven verification and monitoring capabilities.

  • X1 Discovery

    Led · Series B · Oct 2019

    X1 develops search and eDiscovery software built on a distributed architecture that enables compliance, cybersecurity, forensics, privacy, and governance teams to access employee data in place and in real time, whether it resides on laptops, servers, SaaS platforms, or cloud environments. Its Enterprise Suite comprises three main offerings: Distributed Discovery for eDiscovery and eDisclosure, Distributed GRC for governance, risk, compliance and privacy, and Social Discovery for advanced social-media and web data collection. The company reports 600,000 users across 20,000 organizations, establishing it as a global player in enterprise search and compliance tooling. Led by CEO Craig Carpenter and CTO Brent Botta, X1 plans to use new capital to expand its development and sales teams and to grow its global channel network and brand presence. Future initiatives include broadening the capabilities of its Enterprise Suite to capture more governance and privacy use cases. Financially, the firm just secured a $5.1 million Series B and is focused on scaling both its product footprint and market reach.

  • Revenue.io

    Participated · Equity · Nov 2018

    RingDNA provides a sales engagement platform that combines enterprise-grade telephony with conversation intelligence to help sales, support, and customer success teams engage prospects and customers with better context. The platform delivers predictive insights, call coaching, and tools to increase rep productivity. Over the past five years the company has processed more than 60 million conversations, creating an exclusive conversation data network. Customers include Hewlett Packard Enterprise, Amazon Web Services, Autodesk, SAP Concur, Cvent, Lyft, and Twilio. The company says it will use the new financing to accelerate growth. RingDNA is led by founder and CEO Howard Brown and is based in Los Angeles and San Francisco, CA.

  • QLess

    Led · Equity · Nov 2017

    QLess is an industry-leading provider of digital queue management solutions offering virtual check-ins through a dedicated online portal and real-time SMS updates. Its mobile queuing solutions are used in more than 1,000 locations worldwide. The company says the funding will accelerate growth initiatives, expand into new verticals, and advance the total digital queue experience. QLess is privately held, headquartered in Pasadena, and was founded in 2007. Leadership framed the financing as support for broader adoption and product enhancements across customer segments. QLess offers a data-driven customer interaction management (CIM) platform centered on mobile queuing and digital tools to reduce wait times and improve service delivery. Its mobile queuing solutions are used in more than 1,000 locations worldwide. The company reports its platform has helped organizations save over 100 million customers a combined 5,700 years of wasted time. QLess emphasizes analytics and productivity improvements to boost customer satisfaction and employee efficiency. Headquartered in Pasadena, California, the company was founded in 2007 and remains privately held. The recent financing is intended to support continued strategic expansion of the platform across businesses, governments, health providers, and educational institutions. QLess offers a cloud-based interactive platform that leverages learning algorithms to manage customer queues and deliver accurate wait times. The system enables employees to communicate wait times via text or phone message and notifies customers when it is their turn. Management users can access real-time reporting and analytics through the platform. Its queue management software is used across a diverse range of industries. Key partnerships include Vodafone, Dow Chemical, Renown Medical Group, the University of Texas, and government offices in Michigan, Nevada, Texas, New Jersey, and Kansas. Co-founded in 2007 by Alex Bäcker and Tim McCune, QLess secured US$3.5M in growth funding from Wellington Financial in March 2016.

Team

  • Anders Richardson

    Co-Founder, Managing Director

    LinkedIn
  • Paul D'Addario

    Co Founder and managing Partner

    LinkedIn
  • Jeff Anderson

    General Partner

    LinkedIn